Inhibition of STAT3 reduces proliferation and invasion in salivary gland adenoid cystic carcinoma

American Journal of Cancer Research

Volumn 5, Issue 5, 2015, Pages 1751-1761

  Bu, Lin Lin ^a   Deng, Wei Wei ^a   Huang, Cong Fa ^a   Liu, Bing ^a   Zhang, Wen Feng ^a   Sun, Zhi Jun ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Adenoid cystic carcinoma; CD147; Cyclin D1; S3I 201; STAT3

Indexed keywords

EID: 85006216381     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sun ZJ, Chen G, Zhang W, Hu X, Huang CF, Wang YF, Jia J and Zhao YF. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase. J Pharmacol Exp Ther 2010; 334: 500-512.
2. Patel KJ, Pambuccian SE, Ondrey FG, Adams GL and Gaffney PM. Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma. Oral Oncol 2006; 42: 994-1004.
3. Frierson HF Jr, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, Saku T, Moskaluk CA and Hampton GM. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 2002; 161: 1315-1323.
4. Darnell JE Jr. Reflections on STAT3, STAT5, and STAT6 as fat STATs. Proc Natl Acad Sci U S A 1996; 93: 6221-6224.
5. Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S and Grandis JR. STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo. Cell Growth Differ 2002; 13: 355-362.
6. Lin L, Hutzen B, Zuo M, Ball S, Deangelis S, Foust E, Pandit B, Ihnat MA, Shenoy SS, Kulp S, Li PK, Li C, Fuchs J and Lin J. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells. Cancer Res 2010; 70: 2445-2454.
7. Lin L, Amin R, Gallicano GI, Glasgow E, Jogunoori W, Jessup JM, Zasloff M, Marshall JL, Shetty K, Johnson L, Mishra L and He AR. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene 2009; 28: 961-972.
8. Liao Y, Zeng H, Wang X, Huang Y, Chen N, Ge B, Tang L and Luo Q. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland. Exp Eye Res 2009; 88: 4-11.
9. Yu H, Lee H, Herrmann A, Buettner R and Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer 2014; 14: 736-746.
10. Huang J, Lyu H, Wang J and Liu B. MicroRNA regulation and therapeutic targeting of survivin in cancer. Am J Cancer Res 2015; 5: 20-31.
11. Pestell RG. New roles of cyclin D1. Am J Pathol 2013; 183: 3-9.
12. Zhou CX and Gao Y. Aberrant expression of beta-catenin, Pin1 and cylin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis. Oncol Rep 2006; 16: 505-511.
13. Choi MJ, Cho KH, Lee S, Bae YJ, Jeong KJ, Rha SY, Choi EJ, Park JH, Kim JM, Lee JS, Mills GB and Lee HY. hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness. Oncogene 2014.
14. Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z and You T. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression. Cancer Lett 2014; 355: 130-140.
15. Zhao ZL, Ma SR, Wang WM, Huang CF, Yu GT, Wu TF, Bu LL, Wang YF, Zhao YF, Zhang WF, Sun ZJ. Notch signaling induces epithelial-mesenchymal transition to promote invasion and metastasis in adenoid cystic carcinoma. Am J Transl Res 2015; 7: 162-174.
16. Huang C, Sun Z, Sun Y, Chen X, Zhu X, Fan C, Liu B, Zhao Y and Zhang W. Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma. Histopathology 2012; 60: 793-803.
17. Wang SJ, Cui HY, Liu YM, Zhao P, Zhang Y, Fu ZG, Chen ZN and Jiang JL. CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells. Oncotarget 2015; 6: 243-257.
18. Yu GT, Bu LL, Zhao YY, Liu B, Zhang WF, Zhao YF, Zhang L and Sun ZJ. Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma. Am J Cancer Res 2014; 4: 764-775.
19. Wang YF, Ma SR, Wang WM, Huang CF, Zhao ZL, Liu B, Zhang WF, Zhao YF, Zhang L and Sun ZJ. Inhibition of survivin reduces HIF-1alpha, TGF-beta1 and TFE3 in salivary adenoid cystic carcinoma. PLoS One 2014; 9: e114051.
20. Wang YF, Zhang W, He KF, Liu B, Zhang L, Zhang WF, Kulkarni AB, Zhao YF and Sun ZJ. Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma. Apoptosis 2014; 19: 748-758.
21. Zhang L, Sun ZJ, Bian Y and Kulkarni AB. MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma. Cancer Lett 2013; 331: 230-238.
22. Mano Y, Aishima S, Fujita N, Tanaka Y, Kubo Y, Motomura T, Taketomi A, Shirabe K, Maehara Y and Oda Y. Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma. Pathobiology 2013; 80: 146-154.
23. Wendt MK, Balanis N, Carlin CR and Schiemann WP. STAT3 and epithelial-mesenchymal transitions in carcinomas. JAKSTAT 2014; 3: e28975.
24. Jeon YJ, Jung SN, Yun J, Lee CW, Choi J, Lee YJ, Han DC and Kwon BM. Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of STAT3 activity. Cancer Sci 2015; 106: 413-20.
25. Xiao H, Bid HK, Jou D, Wu X, Yu W, Li C, Houghton PJ and Lin J. A Novel Small Molecular STAT3 Inhibitor, LY5 Inhibits Cell Viability, Cell Migration, And Angiogenesis in Medullo-blastoma Cells. J Biol Chem 2015; 290: 3418-29.
26. Hu QD, Chen W, Yan TL, Ma T, Chen CL, Liang C, Zhang Q, Xia XF, Liu H, Zhi X, Zheng XX, Bai XL, Yu XZ and Liang TB. NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithe lial-mesenchymal transition in hepatocellular carcinoma cells. Cancer Lett 2012; 325: 207-213.
27. Zhang C, Yang X, Zhang Q, Guo Q, He J, Qin Q, Zhu H, Liu J, Zhan L, Lu J, Liu Z, Xu L, Ma J, Dai S, Cheng H and Sun X. STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1alpha. Tumour Biol 2014; 35: 9793-9799.
28. Jin HO, Lee YH, Park JA, Kim JH, Hong SE, Kim HA, Kim EK, Noh WC, Kim BH, Ye SK, Chang YH, Hong SI, Hong YJ, Park IC and Lee JK. Blockage of Stat3 enhances the sensitivity of NSCLC cells to PI3K/mTOR inhibition. Biochem Biophys Res Commun 2014; 444: 502-508.
29. Lin HY, Chiang CH and Hung WC. STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells. Br J Cancer 2013; 109: 731-738.
30. Wang X, Goldstein D, Crowe PJ and Yang JL. Impact of STAT3 inhibition on survival of osteosarcoma cell lines. Anticancer Res 2014; 34: 6537-6545.